DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2021$11,782,000
-38.2%
110,000
-40.7%
0.25%
-33.6%
Q3 2021$19,056,000
-23.1%
185,354
-34.2%
0.37%
-15.5%
Q2 2021$24,783,000
+22.0%
281,754
+34.8%
0.44%
+3.0%
Q1 2021$20,321,000
-55.3%
209,000
-48.4%
0.43%
-52.5%
Q4 2020$45,464,000
+21.0%
405,3860.0%0.90%
-1.7%
Q3 2020$37,579,000
+18.8%
405,3860.0%0.92%
-0.7%
Q2 2020$31,620,000
+18.1%
405,386
-11.5%
0.92%
+8.4%
Q1 2020$26,782,000
-40.8%
457,968
-18.9%
0.85%
-41.1%
Q4 2019$45,255,000
+63.3%
564,914
+49.8%
1.44%
+27.8%
Q3 2019$27,713,000
-24.9%
377,200
-3.6%
1.13%
-14.8%
Q2 2019$36,907,000
-9.0%
391,254
-22.8%
1.33%
-14.8%
Q1 2019$40,575,000
+44.5%
506,865
-2.7%
1.56%
+38.4%
Q4 2018$28,087,000
-31.5%
521,000
-0.8%
1.12%
-23.4%
Q3 2018$40,982,000
+35.9%
525,000
+10.5%
1.47%
+38.6%
Q2 2018$30,150,000
-13.2%
474,950
+25.3%
1.06%
-12.0%
Q1 2018$34,750,000
+16.4%
378,950
-4.3%
1.20%
+2.5%
Q4 2017$29,862,000
+111.1%
396,000
+95.1%
1.18%
+84.5%
Q3 2017$14,143,000
+37.5%
203,0000.0%0.64%
+16.0%
Q2 2017$10,286,000
-81.2%
203,000
-85.1%
0.55%
-73.9%
Q1 2017$54,586,000
+5.6%
1,365,000
-25.9%
2.10%
-1.0%
Q4 2016$51,680,000
+707.1%
1,842,415
+754.6%
2.13%
+613.4%
Q3 2016$6,403,000215,5860.30%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders